| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | NEUTRAL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 34.84▲ | 34.83▲ | 34.78▲ | 34.83▲ | 29.54▲ |
| MA10 | 34.87▲ | 34.85▲ | 35.19▼ | 33.20▲ | 25.53▲ |
| MA20 | 34.81▲ | 35.23▼ | 35.39▼ | 30.43▲ | 20.32▲ |
| MA50 | 34.94▼ | 35.31▼ | 34.17▲ | 25.32▲ | 13.53▲ |
| MA100 | 35.28▼ | 33.90▲ | 32.17▲ | 19.96▲ | N/A |
| MA200 | 35.43▼ | 31.92▲ | 28.88▲ | 14.42▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.021▲ | -0.054▼ | -0.206▼ | 0.302▲ | 1.625▲ |
| RSI | 51.209▲ | 46.710▼ | 49.886▼ | 65.137▲ | 79.295▲ |
| STOCH | 27.580 | 42.497 | 43.732 | 83.744▲ | 77.994 |
| WILL %R | -60.417 | -51.765 | -54.646 | -16.632▲ | -7.287▲ |
| CCI | -49.723 | -23.623 | -72.755 | 81.730 | 163.772▲ |
|
Wednesday, November 12, 2025 04:15 AM
Obexelimab Phase 3 INDIGO trial topline results in Immunoglobulin G4-Related Disease (IgG4-RD) expected around year-end 2025 - - Reported highly positive 12-week primary endpoint results from Phase 2 ...
|
|
Tuesday, November 11, 2025 02:04 AM
Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development ...
|
|
Friday, October 31, 2025 09:41 AM
Investing in biotechnology often feels like navigating a minefield. A single failed clinical trial can decimate a stock, while a blockbuster approval can generate spectacular returns. For many ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 33.83 | 35.67 | 33.00 | 35.00 | 281,901 |
| 13/11/25 | 35.22 | 36.295 | 34.0467 | 35.66 | 438,685 |
| 12/11/25 | 36.00 | 36.62 | 35.165 | 35.80 | 250,083 |
| 11/11/25 | 32.58 | 35.98 | 32.28 | 35.20 | 421,255 |
| 10/11/25 | 34.81 | 35.65 | 32.41 | 32.47 | 552,700 |
| 07/11/25 | 32.18 | 34.1499 | 30.86 | 33.61 | 338,472 |
| 06/11/25 | 30.955 | 32.755 | 30.10 | 32.46 | 374,800 |
| 05/11/25 | 30.31 | 31.12 | 29.0001 | 30.53 | 271,356 |
| 04/11/25 | 30.33 | 32.008 | 29.632 | 29.95 | 418,146 |
| 03/11/25 | 31.17 | 31.56 | 30.30 | 31.33 | 425,700 |
|
|
||||
|
|
||||
|
|